Literature DB >> 22178382

Nanotoxicology and in vitro studies: the need of the hour.

Sumit Arora1, Jyutika M Rajwade, Kishore M Paknikar.   

Abstract

Nanotechnology is considered as one of the key technologies of the 21st century and promises revolution in our world. Objects at nano scale, take on novel properties and functions that differ markedly from those seen in the corresponding bulk counterpart primarily because of their small size and large surface area. Studies have revealed that the same properties that make nanoparticles so unique could also be responsible for their potential toxicity. Nanotechnology is rapidly advancing, with more than 1000 nanoproducts already on the market. Considering the fact that intended as well as unintended exposure to nanomaterials is increasing and presently no clear regulatory guideline(s) on the testing/evaluation of nanoparticulate materials are available, the in vitro toxicological studies become extremely relevant and important. This review presents a summary of nanotoxicology and a concise account of the in vitro toxicity data on nanomaterials. For nanomaterials to move into the applications arena, it is important that nanotoxicology research uncovers and understands how these multiple factors influence their toxicity so that the ensuing undesirable effects can be avoided.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22178382     DOI: 10.1016/j.taap.2011.11.010

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  79 in total

1.  Titanium dioxide nanoparticles activate the ATM-Chk2 DNA damage response in human dermal fibroblasts.

Authors:  Raju Y Prasad; Paul D Chastain; Nana Nikolaishvili-Feinberg; Lisa Smeester; William K Kaufmann; Rebecca C Fry
Journal:  Nanotoxicology       Date:  2012-08-23       Impact factor: 5.913

Review 2.  Immunotoxicological impact of occupational and environmental nanoparticles exposure: The influence of physical, chemical, and combined characteristics of the particles.

Authors:  Paola Pedata; Claudia Petrarca; Elpidio Maria Garzillo; Mario Di Gioacchino
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

3.  Assessment of the in vitro dermal irritation potential of cerium, silver, and titanium nanoparticles in a human skin equivalent model.

Authors:  Vivek A Miyani; Michael F Hughes
Journal:  Cutan Ocul Toxicol       Date:  2016-08-08       Impact factor: 1.820

Review 4.  Cytokines as biomarkers of nanoparticle immunotoxicity.

Authors:  Mahmoud Elsabahy; Karen L Wooley
Journal:  Chem Soc Rev       Date:  2013-06-21       Impact factor: 54.564

5.  Interference of the co-exposure of mercury with silica-coated iron oxide nanoparticles can modulate genotoxicity induced by their individual exposures--a paradox depicted in fish under in vitro conditions.

Authors:  Iram Mohmood; Iqbal Ahmad; Mohammad Asim; Leonor Costa; Cláudia B Lopes; Tito Trindade; Armando C Duarte; Eduarda Pereira
Journal:  Environ Sci Pollut Res Int       Date:  2014-09-27       Impact factor: 4.223

6.  Counter ions and constituents combination affect DODAX : MO nanocarriers toxicity in vitro and in vivo.

Authors:  Ana Cristina Norberto Oliveira; Marisa Passos Sárria; Pedro Moreira; Joana Fernandes; Lisandra Castro; Ivo Lopes; Manuela Côrte-Real; Artur Cavaco-Paulo; Maria Elisabete Cunha Dias Real Oliveira; Andreia Castro Gomes
Journal:  Toxicol Res (Camb)       Date:  2016-06-13       Impact factor: 3.524

Review 7.  Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications.

Authors:  Raziye Mohammadpour; Marina A Dobrovolskaia; Darwin L Cheney; Khaled F Greish; Hamidreza Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2019-07-08       Impact factor: 15.470

8.  In Situ Detection and Single Cell Quantification of Metal Oxide Nanoparticles Using Nuclear Microprobe Analysis.

Authors:  Giovanna Muggiolu; Marina Simon; Nathanael Lampe; Guillaume Devès; Philippe Barberet; Claire Michelet; Marie-Hélène Delville; Hervé Seznec
Journal:  J Vis Exp       Date:  2018-02-03       Impact factor: 1.355

Review 9.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

Review 10.  Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.

Authors:  Mahdi Karimi; Amir Ghasemi; Parham Sahandi Zangabad; Reza Rahighi; S Masoud Moosavi Basri; H Mirshekari; M Amiri; Z Shafaei Pishabad; A Aslani; M Bozorgomid; D Ghosh; A Beyzavi; A Vaseghi; A R Aref; L Haghani; S Bahrami; Michael R Hamblin
Journal:  Chem Soc Rev       Date:  2016-03-07       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.